Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery

被引:62
作者
Jebali, Mohamed Adel
Hausfater, Pierre
Abbes, Zoubeir
Aouni, Zied
Riou, Bruno
Ferjani, Mustapha
机构
[1] Hop Mil Tunis, Dept Anesthesiol & Crit Care, Tunis, Tunisia
[2] Hop Mil Tunis, Dept Pharm, Tunis, Tunisia
关键词
D O I
10.1097/01.anes.0000271871.07395.ad
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Cardiopulmonary bypass induces a nonspecific inflammatory response. Procalcitonin has been advocated as a specific biomarker for infection. The authors studied the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery and compared it with those of C-reactive protein, white blood cell count, and interleukins 6 and 8. Methods: The authors prospectively included 100 patients scheduled to undergo elective cardiac procedures with cardio-pulmonary bypass. Blood samples were taken before surgery and each day over the 7-day postoperative period, and measurement of procalcitonin, C-reactive protein, white blood cell count, and interleukins 6 and 8 were performed. Diagnosis of infection was performed by a blinded expert panel. Data are expressed as value [95% confidence interval]. Results: Infection was diagnosed in 16 patients. Procalcitonin was significantly higher in infected patients, with a peak reached on the third postoperative day. Only the areas under the receiver operating curve of procalcitonin (0.88 [0.71-0-951) and C-reactive protein (0.72 [0-58-0-821) were significantly different from the no-discrimination curve, and that of procalcitonin was significantly different from those of C-reactive protein, white blood cell count, and interleukins 6 and 8. A procalcitonin value greater than 1.5 ng/ml beyond the second day diagnosed postoperative infection with a sensitivity of 0.93 [0.70-0.99] and a specificity of 0.80 [0.70-0.87]. Procalcitonin was significantly higher in patients who died (27.5 [1.65-40-51 vs. 1.2 [0.7-1-5] ng/ml; P < 0.001). Conclusion: Procalcitonin is a valuable marker of bacterial infections after cardiac surgery.
引用
收藏
页码:232 / 238
页数:7
相关论文
共 38 条
[1]   Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation [J].
Abraham, E ;
Matthay, MA ;
Dinarello, CA ;
Vincent, JL ;
Cohen, J ;
Opal, SM ;
Glauser, M ;
Parsons, P ;
Fisher, CJ ;
Repine, JE .
CRITICAL CARE MEDICINE, 2000, 28 (01) :232-235
[2]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[3]   Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations [J].
Aouifi, A ;
Piriou, V ;
Blanc, P ;
Bouvier, H ;
Bastien, O ;
Chiari, P ;
Rousson, R ;
Evans, R ;
Lehot, JJ .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (04) :602-607
[4]   Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients [J].
Aouifi, A ;
Piriou, V ;
Bastien, O ;
Blanc, P ;
Bouvier, H ;
Evans, R ;
Célard, M ;
Vandenesch, F ;
Rousson, R ;
Lehot, JJ .
CRITICAL CARE MEDICINE, 2000, 28 (09) :3171-3176
[5]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[6]   Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit [J].
Balci, C ;
Sungurtekin, H ;
Gürses, E ;
Sungurtekin, U ;
Kaptanoglu, B .
CRITICAL CARE, 2003, 7 (01) :85-90
[7]  
Baykut D, 2000, Eur J Med Res, V5, P530
[8]   Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children [J].
Beghetti, M ;
Rimensberger, PC ;
Kalangos, A ;
Habre, W ;
Gervaix, A .
CARDIOLOGY IN THE YOUNG, 2003, 13 (02) :161-167
[9]   Diagnostic value of procalcitonin: the influence of cardiopulmonary bypass, aprotinin, SIRS, and sepsis [J].
Boeken, U ;
Feindt, P ;
Petzold, T ;
Klein, M ;
Micek, M ;
Seyfert, UT ;
Mohan, E ;
Schulte, HD ;
Gams, E .
THORACIC AND CARDIOVASCULAR SURGEON, 1998, 46 (06) :348-351
[10]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655